Supriya Lifescience Limited (SUPRIYA) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.76x

Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Reinvestment Rate of 0.76x as of September 2025, reinvesting Rs422.49 Million (capex Rs422.49 Million ) from operating cash flow of Rs555.65 Million. Explore Supriya Lifescience Limited capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.76x
(Capex + Investments) / Operating CF

Total Reinvested

Rs422.49 Million
Capex + Investments

Operating Cash Flow

Rs555.65 Million
INR

Capital Expenditures

Rs422.49 Million
INR

Supriya Lifescience Limited Cash Flow Reinvestment Rate (2018–2025)

Historical reinvestment intensity for Supriya Lifescience Limited across 8 annual periods. Also explore SUPRIYA total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Supriya Lifescience Limited (2018–2025)

Year-by-year capital reinvestment analysis for Supriya Lifescience Limited. For live market cap and broader valuation context, see market cap of Supriya Lifescience Limited.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 1.82x Rs3.15 Billion Rs1.73 Billion Rs1.62 Billion ▼ -35.3%
2024 2.82x Rs3.19 Billion Rs1.13 Billion Rs1.46 Billion ▼ -22.8%
2023 3.65x Rs2.42 Billion Rs661.87 Million Rs1.08 Billion ▲ +48.8%
2022 2.45x Rs1.20 Billion Rs488.01 Million Rs599.04 Million ▲ +105.0%
2021 1.20x Rs956.51 Million Rs799.30 Million Rs482.41 Million ▲ +183.2%
2020 0.42x Rs490.50 Million Rs1.16 Billion Rs245.25 Million ▲ +193.3%
2019 0.14x Rs70.13 Million Rs486.72 Million Rs69.45 Million ▼ -49.7%
2018 0.29x Rs49.98 Million Rs174.52 Million Rs49.30 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow